Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A

NCT00038935 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: ReFacto AF

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer